Compounded Peptides at a Crossroads: Will Regulators Finally Get Out of the Way?
After years of restriction driven by theoretical risks, momentum is building in Washington to restore access to peptides. Action Alert! Listen to the audio version of this article: THE TOPLINE After years of increasing suppression under the FDA, access to peptide bioregulators may finally be opening up. Signals from RFK Jr. suggest that regulators are […]









